Selegiline reduces adiposity induced by high‐fat, high‐sucrose diet in male rats
Authors:
- 3 July 2018
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 175 (18) , 3713-3726
Abstract
Background and Purpose: Incidence and severity of obesity are increasing worldwide, however, efficient and safe pharmacological treatments are not yet available. Certain MAO inhibitors reduce body weight, although their effects on metabolic parameters have not been investigated. Here, we have assessed effects of a widely used, selective MAO‐B inhibitor, selegiline, on metabolic parameters in a rat model of diet‐induced obesity.Experimental Approach: Male Long–Evans rats were given control (CON) or a high‐fat (20%), high‐sucrose (15%) diet (HFS) for 25 weeks. From week 16, animals were injected s.c. with 0.25 mg·kg−1 selegiline (CON + S and HFS + S) or vehicle (CON, HFS) once daily. Whole body, subcutaneous and visceral fat was measured by CT, and glucose and insulin tolerance were tested. Expression of glucose transporters and chemokines was assessed by quantitative RT‐PCR.Key Results: Selegiline decreased whole body fat, subcutaneous‐ and visceral adiposity, measured by CT and epididymal fat weight in the HFS group, compared with HFS placebo animals, without influencing body weight. Oral glucose tolerance and insulin tolerance tests showed impaired glucose homeostasis in HFS and HFS + S groups, although insulin levels in plasma and pancreas were unchanged. HFS induced expression of Srebp‐1c, Glut1 and Ccl3 in adipose tissue, which were alleviated by selegiline.Conclusions and Implications: Selegiline reduced adiposity, changes in adipose tissue energy metabolism and adipose inflammation induced by HFS diet without affecting the increased body weight, impairment of glucose homeostasis, or behaviour. These results suggest that selegiline could mitigate harmful effects of visceral adiposity.Keywords
Funding Information
- Magyar Tudományos Akadémia (János Bolyai Fellowship, Premium Postdoctoral Fellowship Programme)
- Semmelweis Egyetem (EFOP‐3.6.3‐VEKOP‐16‐2017‐00009)
- Országos Tudományos Kutatási Alapprogramok (OTKA K 109737)
This publication has 51 references indexed in Scilit:
- Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesisNature, 2011
- The effect of selegiline on total scavenger capacity and liver fat content: a preliminary study in an animal modelJournal of Neural Transmission, 2011
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Antidepressant Phenelzine Alters Differentiation of Cultured Human and Mouse PreadipocytesMolecular Pharmacology, 2009
- Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitorsPharmacological Research, 2008
- Assessment of Diet‐induced Obese Rats as an Obesity Model by Comparative Functional GenomicsObesity, 2008
- Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker ratsPharmacological Research, 2007
- Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophyProceedings of the National Academy of Sciences, 2006
- Link between obesity and type 2 diabetesBest Practice & Research Clinical Endocrinology & Metabolism, 2005
- The possible mechanisms of action of (-)deprenyl in Parkinson's diseaseJournal of Neural Transmission, 1978